DEPLOY

Buying guide

Stelo vs Whoop (5.0 / MG) in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

  • Whoop (5.0 / MG) has more capabilities independently verified as autonomous (2 vs 0).
  • Stelo has the lower recorded price.
Attribute
ManufacturerDexcomWhoop
Form factorbiometricbiometric
Maturitycommercialcommercial
Autonomy2 verified autonomous
Availabilityshipping-nowshippingshipping-nowshipping
Price$89-$99 (actual sale price)$199-$359/year lease (actual sale price)
Capability claims
  • Tracks sleep (autonomous, verified)
  • Tracks stress and recovery (autonomous, verified)
  • Tracks heart health (claimed-only, claimed)
  • Tracks body temperature (claimed-only, claimed)
Brain
Verified deployments1Global1Global
Privacy practices4biometric-storage, training-data-use, third-party-sharing, data-deletion-control13data-retention, third-party-sharing, data-sale, third-party-sharing, biometric-storage, training-data-use, data-deletion-control, third-party-sharing, location-tracking, data-sale, data-deletion-control, data-retention, biometric-storage
Sources on file1122

Editorial summaries

Stelo

Dexcom's Stelo is the first-ever FDA-cleared over-the-counter (no-prescription) glucose biosensor (De Novo, March 5, 2024; US launch August 26, 2024): a 15-day continuous glucose monitor for adults 18+ not on insulin (type 2 not on insulin, plus non-diabetic users tracking how diet and exercise affect glucose). It is the generative-AI end of the glucose cell: Weekly Insights run on Google Cloud's Vertex AI and Gemini, with AI photo meal-logging and personalized daily recommendations, the AI substance that carries it across the biometric boundary. Pricing is about $89 for a 2-week sensor on a biweekly subscription model (around $99/month). From DexCom (NASDAQ: DXCM), Stelo is the OTC product line, separate from the prescription G7. Cap-flag: the cleared indication is an OTC CGM for adults 18+ not on insulin; it is explicitly NOT cleared for problematic hypoglycemia and has no low-glucose alerts, so it should not be read as a diabetes-management device.

Whoop (5.0 / MG)

Whoop (the 5.0 and the 'Medical Grade' MG, both launched May 8, 2025, from Whoop, founded 2012 in Boston by Will Ahmed) is a screen-free biometric wrist band and the subscription-only archetype of the biometric cohort: there is no standalone hardware sale. Access is a membership, Whoop One at $199/year, Peak at $239/year, and Life at $359/year (which includes the MG hardware), with the band provided inside the subscription. Its PPG, skin-temperature, SpO2, and respiratory sensors feed Strain, Recovery, and Sleep Coach analytics and an LLM 'Whoop Coach'; the MG adds ECG, Blood Pressure Insights, and a Healthspan / 'Whoop Age' feature. DEPLOY records commercial maturity and a reported $10.1 billion valuation (March 2026). Whoop is the strongest verified-vs-claimed cautionary exemplar in the cohort: its ECG is FDA-cleared (2025), but it marketed Blood Pressure Insights without clearance, drew an FDA Warning Letter on July 14, 2025, refused to remove the feature, and as of May 2026 the matter is unresolved with a class action filed, the market-first contrast to Oura's study-first posture.

Common questions

What is the difference between Stelo and Whoop (5.0 / MG)?
Stelo and Whoop (5.0 / MG) are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which is cheaper, Stelo or Whoop (5.0 / MG)?
Stelo has the lower recorded price on the DEPLOY registry than Whoop (5.0 / MG). Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
Is Stelo or Whoop (5.0 / MG) more autonomous?
Whoop (5.0 / MG) has more capabilities independently verified as autonomous on the DEPLOY registry than Stelo. DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
Which has more verified deployments, Stelo or Whoop (5.0 / MG)?
Stelo and Whoop (5.0 / MG) each have 1 verified deployment on the DEPLOY registry (confirmed at named sites with primary sources).

Recent coverage

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.


Machine-readable: this page as markdown.

← Back to all consumer robots